false
0001534154
0001534154
2026-10-05
2026-10-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 5, 2026
authID Inc.
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-40747 |
|
46-2069547 |
(State or other jurisdiction of
incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
1580 N. Logan St., Suite 660, Unit 51767, Denver,
Colorado 80203
(Address of principal executive offices) (Zip
Code)
Registrant’s telephone number, including
area code: (516) 274-8700
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| | |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| | |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, par value $0.0001 per share |
|
AUID |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ☐
Item
1.01 Entry into a Material Definitive Agreement.
Securities Purchase Agreement
On October 5, 2026, authID Inc. (the “Company”)
entered into a Securities Purchase Agreement (the “Purchase Agreement”) with four accredited investors (the “Investors”)
pursuant to which the Company agreed to issue and sell to the Investors, in a private placement (the “Offering”), (i) senior
secured convertible debentures in the aggregate original principal amount of $1,350,000 (the “Debentures”) and (ii) warrants
to purchase up to an aggregate of 1,800,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common
Stock”), at an exercise price of $0.50 per share (the “Warrants”). The Warrants provide coverage equal to one and one-third
(4/3) of the principal amount of Debentures purchased by each Investor. The Debentures were sold at their principal amount, with no original
issue discount. None of the Investors is an officer, director or affiliate of the Company.
The closing of the Offering occurred on October
6, 2026. The aggregate gross proceeds to the Company from the Offering are $1,350,000, before deducting placement agent fees and other
Offering expenses. The Company intends to use the net proceeds of the Offering for working capital and general corporate purposes. Under
the Purchase Agreement, the Company may not use the proceeds to repay indebtedness (other than trade payables in the ordinary course),
to redeem any Common Stock or Common Stock equivalents, to settle litigation, or to make loans or advances to officers, directors, employees
or affiliates.
The Purchase Agreement contains customary representations,
warranties and covenants of the Company and the Investors, including an agreement by the Company to indemnify the Investors against losses
arising from any breach of the Company’s representations, warranties or covenants, and a covenant to maintain a reserve of authorized
but unissued shares of Common Stock sufficient for issuance upon conversion of the Debentures and exercise of the Warrants. The Purchase
Agreement also provides that the Warrants shall not be exercisable, and the Company shall not be obligated to issue any shares of Common
Stock upon exercise of the Warrants, unless and until the Company’s stockholders have approved the issuance of the shares of Common
Stock issuable upon exercise of the Warrants in accordance with Nasdaq Listing Rule 5635 (“Stockholder Approval”). The Company
has agreed to use its commercially reasonable efforts to obtain Stockholder Approval at the next annual or special meeting of stockholders
held following the closing of the Offering.
Madison Global Partners, LLC (the “Placement
Agent”) acted as non-exclusive placement agent for the Offering pursuant to an engagement letter dated October 3, 2026. The Company
agreed to pay the Placement Agent a cash fee equal to 7% of the gross proceeds of the Offering and to issue to the Placement Agent (or
its designees) warrants to purchase shares of Common Stock having a value equal to 7% of the gross proceeds of the Offering (the “Placement
Agent Warrants”) exercisable at $0.386 per share, and to reimburse $25,000 of the Placement Agent’s legal fees.
Debentures
The Debentures mature on the earlier of February
28, 2027 and the consummation of a Change of Control Transaction (as defined in the Debentures) (the “Maturity Date”). The
Debentures do not bear interest. The Debentures are senior secured obligations of the Company and rank pari passu in right of payment
and in lien priority with the Company’s senior secured debentures issued on April 29, 2026 (the “April 2026 Debentures”)
as amended pursuant to the Backstop Commitment Agreement dated September 9, 2026. The Company has agreed not to incur indebtedness senior
to the Debentures or grant liens on its assets other than Permitted Liens (as defined in the Security Agreement described below) without
the consent of the holders.
The Debentures are convertible, in whole or in
part, at the option of each holder at any time into shares of Common Stock (the “Conversion Shares”) at a conversion price
of $0.386 per share (the “Conversion Price”), which was the “Minimum Price” under Nasdaq Listing Rule 5635(d)
at the time the Purchase Agreement was signed. The Conversion Price is subject to adjustment for stock splits, stock dividends, combinations
and similar events, but does not contain price-based anti-dilution protection. Based on the Conversion Price, the Debentures are convertible
into an aggregate of 3,497,409 shares of Common Stock. A holder may not convert its Debenture to the extent that, after giving effect
to the conversion, the holder (together with its affiliates) would beneficially own more than 4.99% or 9.99%, as applicable, of the outstanding
Common Stock, which limitation may be adjusted by the holder on 61 days’ notice but not above 9.99%. In addition, the Company may
not issue Conversion Shares to the extent that such issuance, together with the shares issued under the other transaction documents, would
exceed the number of shares the Company may issue without stockholder approval under Nasdaq Listing Rule 5635, unless and until such approval
is obtained.
The Debentures contain customary events of default,
including failure to pay principal when due, bankruptcy and insolvency events, a default under other indebtedness in excess of $200,000
that is accelerated, the Common Stock ceasing to be quoted or listed on a Primary Market (as defined in the Debentures) for five consecutive
trading days, a material breach of the Debentures or the other transaction documents that is not cured within the applicable cure period,
failure to maintain the required share reserve, and the security interest securing the Debentures ceasing to be a perfected first-priority
lien (pari passu with the April 2026 Debentures). Upon an event of default, each holder may declare its Debenture immediately due and
payable. The Debentures may be amended with the consent of the Company and holders of not less than 67% of the outstanding principal amount,
except that no amendment may require the conversion of any holder’s Debenture without that holder’s consent. The holders have
consented to a reverse stock split effected to maintain the listing of the Common Stock on Nasdaq.
Warrants
The Warrants have an exercise price of $0.50 per
share, a term of five years from the date of issuance, and may be exercised on a cashless basis at the holder’s election. The Warrants
are not exercisable unless and until Stockholder Approval is obtained. The exercise price and number of shares issuable upon exercise
of the Warrants (the “Warrant Shares”) are subject to adjustment for stock splits, stock dividends, combinations and similar
events. The Warrants are subject to a beneficial ownership limitation of 4.99% or 9.99%, as applicable, on the same terms as the Debentures.
Security Agreements
In connection with the Offering, the Company entered
into a Security Agreement dated as of October 5, 2026 with each Investor (collectively, the “Security Agreements”), pursuant
to which the Company granted to each Investor a security interest in substantially all of the Company’s assets, including all goods,
equipment, inventory, accounts, deposit accounts, investment property, intellectual property and other general intangibles, and the proceeds
thereof, to secure the Company’s obligations under the Debentures. The security interests granted to the Investors rank pari passu
with the security interests securing the April 2026 Debentures, with ratable sharing of the collateral among the Investors and the holders
of the April 2026 Debentures. The Security Agreements permit certain liens, including the pari passu liens securing the April 2026 Debentures,
tax and statutory liens, and purchase money and equipment lease liens not exceeding $100,000 in the aggregate. Upon an event of default
under the Debentures that remains uncured after any applicable notice and cure period, each Investor may exercise the remedies of a secured
party under the Uniform Commercial Code, including taking possession of and selling the collateral.
Registration Rights Agreement
Also in connection with the Offering, the Company
entered into a Registration Rights Agreement dated as of October 5, 2026 with the Investors (the “Registration Rights Agreement”),
pursuant to which the Company agreed to file a registration statement with the Securities and Exchange Commission (the “SEC”)
covering the resale of the Conversion Shares, the Warrant Shares and the shares of Common Stock issuable upon exercise of the Placement
Agent Warrants within 60 days following the closing of the Offering, and to use its commercially reasonable efforts to cause the registration
statement to be declared effective within 75 days thereafter and to keep it effective until the registrable securities have been sold
or may be sold without restriction under Rule 144. The Registration Rights Agreement also grants the Investors piggyback registration
rights with respect to registration statements filed in connection with or following a merger, reverse merger, business combination, recapitalization,
reorganization, direct listing or similar transaction (other than a prospectus supplement to the Company’s existing shelf registration
statement on Form S-3). The Company may suspend use of the registration statement for not more than 15 consecutive days or 30 days in
any 12-month period. The Registration Rights Agreement does not provide for liquidated damages. The Company may include on the same registration
statement the shares of Common Stock issuable to the holders of the April 2026 Debentures and the related warrants, fee shares and commitment
fee warrants.
Amendment of April 2026 Debentures and Existing Warrants
In connection with the Offering, the holders of
the April 2026 Debentures consented to the Offering and to the pari passu ranking of the Debentures and the related security interests,
waived any right to repayment of the April 2026 Debentures from the proceeds of the Offering, and agreed to extend the maturity date of
the April 2026 Debentures from October 29, 2026 to February 28, 2027. In consideration of the extension, the Company agreed to reduce
the exercise price of the warrants issued to the holders of the April 2026 Debentures on April 29, 2026 from $0.57 per share to $0.50
per share; the reduction in the exercise price of warrants held by directors of the Company is subject to stockholder approval in accordance
with Nasdaq Listing Rule 5635(c).
The foregoing descriptions of the Purchase Agreement,
the Debentures, the Warrants, the Security Agreements, the Registration Rights Agreement and the consent of the holders of the April 2026
Debentures do not purport to be complete and are qualified in their entirety by reference to the full text of the forms of those documents,
which are filed as Exhibits 10.1, 10.2, 10.3, 10.4, 10.5 and 10.6, respectively, to this Current Report on Form 8-K and are incorporated
herein by reference. The representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit
of the parties thereto and may be subject to limitations agreed upon by the contracting parties. Accordingly, the Purchase Agreement is
incorporated herein by reference only to provide investors with information regarding its terms and not to provide investors with any
other factual information regarding the Company or its business, and should be read in conjunction with the disclosures in the Company’s
periodic reports and other filings with the SEC.
Item
2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth under Item 1.01 of this
Current Report on Form 8-K with respect to the Debentures and the Security Agreements, and the extension of the maturity date of the April
2026 Debentures, is incorporated by reference into this Item 2.03.
Item
3.02 Unregistered Sales of Equity Securities.
The information set forth under Item 1.01 of this
Current Report on Form 8-K is incorporated by reference into this Item 3.02. The Debentures, the Warrants and the Placement Agent Warrants
were offered and sold in a private placement in reliance upon the exemption from the registration requirements of the Securities Act of
1933, as amended (the “Securities Act”), afforded by Section 4(a)(2) thereof and Rule 506(b) of Regulation D promulgated thereunder,
without any form of general solicitation or general advertising. Each Investor represented to the Company that it is an “accredited
investor” as defined in Rule 501(a) of Regulation D, that it has such knowledge and experience in financial and business matters
that it is capable of evaluating the merits and risks of the investment, and that it is acquiring the securities for its own account for
investment purposes and not with a view to the distribution thereof. The Debentures, the Warrants, the Placement Agent Warrants, the Conversion
Shares and the Warrant Shares have not been registered under the Securities Act or any state securities laws, bear (or will bear) restrictive
legends, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements.
The reduction of the exercise price of the warrants held by the holders of the April 2026 Debentures was effected in reliance upon the
same exemption.
Based on the Conversion Price of $0.386 per share,
the Debentures are convertible into an aggregate of 3,497,409 shares of Common Stock, and the Warrants are exercisable, subject to Stockholder
Approval, for an aggregate of 1,800,000 shares of Common Stock, in each case subject to adjustment as described in Item 1.01 and to the
beneficial ownership and Nasdaq limitations described therein. The Placement Agent Warrants are exercisable for 244,819 shares of Common
Stock.
Item
7.01 Regulation FD Disclosure.
On October 5, 2026, the Company issued a press
release announcing the pricing of the Offering and the extension of the maturity date of the April 2026 Debentures. A copy of the press
release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
On October 6, 2026, the Company issued a press
release announcing that it had entered into a $2 million technology licensing, services and support agreement with the EinStrong Charitable
Foundation, under which EinStrong paid $1 million for a non-exclusive license of the Company’s biometric identity technology and
committed an additional $1 million for new biometric de-duplication functionality and engineering support. The press release also includes
statements by the Company’s Interim Chief Executive Officer regarding the Company’s business outlook and the reduction of
the Company’s monthly cash operating expenses. A copy of the press release is furnished as Exhibit 99.2 to this Current Report on
Form 8-K.
The information furnished under this Item 7.01,
including Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated
by reference into any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference
in such filing.
Item
8.01 Other Events.
Cautionary Note Regarding Forward-Looking Statements.
This Current Report on Form 8-K contains “forward-looking statements” within the meaning of Section 27A of the Securities
Act and Section 21E of the Exchange Act, including statements regarding the expected closing of the Offering and the satisfaction of closing
conditions, the anticipated use of proceeds, the Company’s ability to obtain Stockholder Approval for the exercise of the Warrants
and the repricing of the warrants held by directors, the filing and effectiveness of the resale registration statement contemplated by
the Registration Rights Agreement, the Company’s ability to repay or refinance the Debentures and the April 2026 Debentures at maturity,
the Company’s ability to regain compliance with the continued listing requirements of Nasdaq, the Company’s business outlook,
the Company’s expectations regarding its cash operating expenses, and the anticipated benefits of and payments under the Company’s
agreement with the EinStrong Charitable Foundation. Forward-looking statements are based on management’s current expectations and
are subject to risks and uncertainties that could cause actual results to differ materially, including the risks that the proceeds of
the Offering will not be sufficient to fund the Company’s operations and liquidity needs, that the Company will be unable to issue
shares of Common Stock upon conversion of the Debentures or exercise of the Warrants beyond the limits permitted by Nasdaq Listing Rule
5635 without stockholder approval, that the resale registration statement will not be filed or declared effective on a timely basis, that
the Company will be unable to repay the Debentures and the April 2026 Debentures when due, that the Company’s Common Stock will
be delisted from Nasdaq, that the Company will not realize the anticipated benefits of its agreement with the EinStrong Charitable Foundation
or receive the additional payments contemplated thereby, and that the Company will be unable to sustain the reduction in its cash operating
expenses, as well as the risk factors described under “Risk Factors” in the Company’s Annual Report on Form 10-K for
the fiscal year ended December 31, 2025 and its subsequent Quarterly Reports on Form 10-Q and other filings with the SEC. Forward-looking
statements speak only as of the date of this report, and the Company undertakes no obligation to update or revise any forward-looking
statement, whether as a result of new information, future events or otherwise, except as required by law.
Item
9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
|
Description |
| 10.1 |
|
Form of Securities Purchase Agreement, dated as of October 5, 2026, between authID Inc. and the Investors named therein* |
| 10.2 |
|
Form of Senior Secured Convertible Debenture issued October 6, 2026 |
| 10.3 |
|
Form of Warrant issued October 6, 2026 |
| 10.4 |
|
Form of Security Agreement, dated as of October 5, 2026, between authID Inc. and each Investor |
| 10.5 |
|
Form of Registration Rights Agreement, dated as of October 5, 2026, between authID Inc. and the Investors named therein |
| 10.6 |
|
Form of Second Notice to and Consent of Holders of April 2026 Senior Secured Debentures, dated October 5, 2026 |
| 10.7 |
|
Form of Placement Agent Warrant |
| 99.1 |
|
Press release of authID Inc. dated October 5, 2026 (furnished pursuant to Item 7.01) |
| 99.2 |
|
Press release of authID Inc. dated October 6, 2026 (furnished pursuant to Item 7.01) |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| * | Certain schedules, appendices and exhibits (including the Confidential
Investor Questionnaire, the Disclosure Schedule and the wire instructions in Section 2.03(c)) have been omitted pursuant to Item 601(a)(5)
of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request. |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
authID Inc. |
| |
|
| Date: October 8, 2026 |
By: |
/s/ Thomas R. Szoke |
| |
Name: |
Thomas R. Szoke |
| |
Title: |
Interim Chief Executive Officer |
Exhibit 99.1

authID Announces Pricing of Up To $1,350,000 Private Placement Offering
Holders of Debentures Issued in April 2026 Agree to Extend Maturity
through February 2027
DENVER, Oct. 05, 2026 (GLOBE NEWSWIRE) -- authID
Inc. (NASDAQ: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and
authentication solutions, today announced it has entered into a definitive agreement with investors to sell Senior Secured Convertible
Debentures (the “Debentures”) and Warrants to purchase shares of the Company’s common stock (the “Warrants”)
pursuant to a private placement offering (the “Offering”).
The Debentures are convertible into Common Stock at the option of each
Holder at a price of $0.386. The Warrants will have an exercise price of $0.50. The conversion of the Debentures, and issuance and exercise
of the Warrants shall remain subject to compliance with applicable securities laws, Nasdaq rules and the Company’s governing documents,
including stockholder approval prior to any exercise of the Warrants.
The aggregate gross proceeds from the Offering are expected to be approximately
$1,350,000 before deducting placement agent fees and other Offering expenses.
The closing of the Offering is expected to occur commencing on or about
October 6, 2026, subject to the satisfaction of customary closing conditions.
In addition the holders of Senior Secured Debentures issued in April
2026, agreed to extend the maturity date of their debentures to February 28, 2027.
Madison Global Partners, LLC acted as a non-exclusive Placement Agent
in connection with the offering. Madison Global Partners, LLC also served as a non-exclusive financial advisor to the Company, providing
strategic guidance throughout the transaction.
In addition to its placement activities, Madison Global Partners, LLC
delivers a range of advisory and investment services, including capital markets advisory, transaction structuring, and strategic financial
consulting. Their involvement reflects the Company’s commitment to leveraging experienced financial partners to support its growth
initiatives and long-term value creation strategy.
authID intends to use the net proceeds for working capital and general
corporate purposes.
The Debentures and the Warrants described above are being offered and
sold in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”),
and/or Regulation D promulgated thereunder. The Debentures, the Warrants, the Conversion Shares and the shares of common stock issuable
upon exercise of the Warrants and Placement Agent Warrants have not been registered under the Securities Act or applicable state securities
laws. Accordingly, these securities may not be reoffered or resold in the United States absent registration with the SEC or an applicable
exemption from such registration requirements.
In connection with the Offering, the parties also entered into a registration
rights agreement, pursuant to which the Company has agreed to file one or more registration statements with the SEC covering the resale
of the shares of common stock issuable upon the exercise of the Warrants, issuable upon Conversion of the Conversion Shares and the Placement
Agent Warrants.
This press release shall not constitute an offer to sell or the solicitation
of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or
sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About authID Inc.
authID (Nasdaq: AUID) ensures enterprises “Know Who's Behind
the Device™” for every customer or employee login and transaction through its easy-to-integrate, patented, biometric identity
platform. authID quickly and accurately verifies a user's identity, leveraging a 1-in-1-billion false positive rate for the highest level
of assurance, coupled with industry-leading speed and privacy-preserving technology. Its IDX platform secures the distributed workforce
of employees and contractors, while enforcing authorization and accountability for AI agents. By creating a biometric root of trust for
each user, authID stops fraud at onboarding, prevents account takeover, detects and stops deepfakes, eliminates password risks and costs,
and provides the fastest, frictionless, and most accurate user identity experience in the industry.
For more information, please visit authID.ai
Investor Relations Contacts
Investor-Relations@authid.ai
Cautionary Statement Regarding Forward-Looking Statements:
This Press Release includes “forward-looking statements.”
All statements other than statements of historical facts included herein are forward-looking statements. Actual results may vary materially
from the results anticipated by these forward-looking statements as a result of a variety of risk factors. See the Company’s Annual
Report on Form 10-K for the Fiscal Year ended December 31, 2025, filed at www.sec.gov
and other documents filed with the SEC for risk factors which investors should consider. These forward-looking statements speak only as
to the date of this release and cannot be relied upon as a guide to future performance. authID expressly disclaims any obligation or undertaking
to disseminate any updates or revisions to any forward-looking statements contained in this release to reflect any changes in its expectations
with regard thereto or any change in events, conditions, or circumstances on which any statement is based.
Exhibit 99.2
authID
Announces $2 Million Agreement with the EinStrong Foundation
EinStrong
invests $2M in authID’s biometric identity technology to secure its mission to fight poverty and educational inequality
DENVER,
October 6, 2026 - authID® (Nasdaq: AUID), a leading provider of biometric identity verification and authentication
solutions, today announced a $2 million technology
licensing, services, and support agreement with the EinStrong Charitable Foundation, an organization dedicated to alleviating
poverty and providing secure and transparent support to vulnerable groups of people around the world.
To
enable the further development of ESi, EinStrong’s universal ID, EinStrong paid $1 million for a non-exclusive authID technology
license and has committed an additional $1 million for new biometric de-duplication functionality and engineering support.
EinStrong
provides direct cash transfers directly to underprivileged populations such as single mothers living in poverty, utilizing authID technology
to positively determine the identities of recipients through biometric identification and verification. EinStrong’s program encourages
the improvement of local environments and the progression of sustainable livelihoods, as well as assisting childhood education.
To
enhance its ability to prevent fraud and ensure that funds are only provided to eligible recipients, EinStrong has
made a significant commitment to the authID technology through investment and product roadmap alignment.
“For
over two years we have been proud participants in EinStrong’s mission to assist less fortunate, at-risk communities,” commented
Thomas Szoke, CEO of authID. “Their commitment to supporting impoverished societies has inspired our designers and developers to
further enhance our tech, allowing them to deter fraudsters and duplicates, and put precious funds in the hands of deserving individuals.”
“We
are excited about our business outlook and the execution of this important agreement,” added Szoke. “Having now reduced our
monthly cash operating expenses by roughly 40% as compared to the first quarter 2026, we start the fourth quarter from a leaner base
that gives us real leverage as the business grows. We remain committed to disciplined execution and to pursuing the best path forward
for authID, its customers and its shareholders.”
“Over
the last two years, our use of authID’s biometric
platform has given our sponsors the confidence to fund our mission knowing that their donations will go only to people in need,”
commented Steven Cho, Chief Operating Officer of EinStrong. “By deepening our investment and partnership with authID, EinStrong
will further extend its innovation and achieve even greater impact as we scale.”
EinStrong’s
proprietary app enables donors to bypass the typical obstacles
to philanthropy, with direct cash donations that most easily benefit needy families across multiple continents. authID
has supported EinStrong’s mission through a seamless biometric identity experience that allows users to easily and securely
assert their identities and gain access to and use donor funds.
About
authID
authID®
(Nasdaq: AUID) ensures enterprises “Know Who’s Behind the Device™” for every customer or employee login and transaction
through its easy-to-integrate, patented, biometric identity platform. authID quickly and accurately verifies a user’s identity
and eliminates any assumption of “who” is behind a device to prevent cybercriminals from compromising account openings or
taking over accounts. Combining secure digital onboarding, biometric authentication, and account recovery with a fast, accurate, user-friendly
experience, authID delivers biometric identity processing in 700ms, with a 1-to-1-billion false match rate and 1-to-many sub-second search
capability. authID delivers all the benefits of biometric identity verification while ensuring complete privacy protection and regulatory
compliance by storing no biometric data whatsoever. For more information, visit authid.ai.
authID
Investor Relations
investor-relations@authID.ai
About
the EinStrong Foundation
The
EinStrong Foundation is a not-for-profit foundation started in 2019, headquartered in Southern California, with additional support from
individuals and organizations in Asia and Europe. They invite other individuals, foundations, educational institutions, NGOs, and philanthropists
to improve the economic, educational, and climate change objectives of people around the world. Their objective is to benefit a billion
people globally in the next 5-10 years.
For
more information, contact info@einstrong.org